Table 1.
Materials | Advantage | Limitations | Feature | Limit of detection | Ref. |
---|---|---|---|---|---|
SWCNT |
Large surface area to volume ratio (S/V) Low charge-carried density Delocalized π-orbitals Electrical conductivity improvements |
Limited surface to interface with large biological components Nonspecific adsorption of protein Difficult manipulation during sensor fabrication process Difficult chemical functionalization |
Electrode |
DeoxyriboNucleic acid (DNA) 71 pM |
[13] |
Electrode |
Glucose 7.06 μA/mM |
[14] | |||
Electrode |
aflatoxin B1 (AFB1) 0.01 nM |
[15] | |||
Electrode |
Anti-IgG 0.2 pM |
[16] | |||
MWCNT |
Excellent conducting and electro-catalytic properties |
Need to functionalize surface for increasing biocompatibility Irreversible agglomerates in aqueous solution |
Electrode |
Carcinoembryonic antigen (CEA) 0.0055 fM |
[17] |
Electrode |
Transforming growth factor beta 1 (TGF-β1) 0.05 pM |
[9] | |||
Electrode |
Prostate specific antigen (PSA) 0.11 fM |
[18] | |||
Electrode |
Mouse IgG 0.066 pM |
[19] | |||
Label |
PSA 0.13 pM |
[20] | |||
Graphene |
High S/V Large active sites Fast electron transfer High thermal conductivity Better mechanical flexibility Good biocompatibility |
Hard to dissolve in water | Electrode |
dibutyl phthalate (DBP) 0.025 μM |
[21] |
Electrode |
PSA 0.33 pM |
[22] | |||
Electrode |
Cystatin C 0.002 nM |
[23] | |||
Label |
Cry1C 0.02 pM |
[24] | |||
Label |
CEA 0.003 pM |
[25] |